Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1993-07-26
1996-03-05
Wu, Shean
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
A61K 5104, A61K 5112
Patent
active
054965330
ABSTRACT:
Rhenium complexes of formula (I), radiolabelled complexes thereof or pharmaceutically acceptable salts thereof: ##STR1## wherein R is straight or branched chain C.sub.1-10 alkyl, C.sub.1-10 alkenyl, C.sub.1-10 alkynyl optionally substituted by cycloalkyl or aryl; C.sub.1-10 cycloalkyl optionally substituted by straight or branched chain alkyl, alkenyl, alkynyl or aryl; or aryl optionally substituted by straight or branched chain alkyl, alkenyl, alkynyl or cycloalkyl for use in liver cancer therapy and metastasis of cancer.
REFERENCES:
patent: 2580695 (1952-01-01), Niederhauser
patent: 4578391 (1986-03-01), Kawata et al.
patent: 4925650 (1990-05-01), Nosco et al.
patent: 4926869 (1990-05-01), Rubin et al.
Mahmood et al., "Stereoisomers of Neutral Oxotechnetium (V) and Oxorhenium (V) Complexes", Technetium and Rhenium in Chemistry & Nuclear Medicine, 3, Edited by M. Nicolini et al., 1990, pp. 119-124.
"Stereoisomers of neutral oxotechneitum(V) complexes", Manhood, et al Technetium and Rhenium in Chemistry and Nuclear Medicine 3 Edited by M. Nicholini et al (1990), pp. 119-124, Raven Press, New York.
"Effect of Arterial Administration of High-molecular weight Anticancer Agents SMANCS with Lipid Lymphographic Agent on Hepatoma: a Preliminary Report," Toshmitisu Konno, et al Eur. J. Cancer Clin. Oncol. 19 No. 8, 1983 pp. 1053-1065.
"Critical Evaluation of 1-131-Lipiodol Therapy for Hepatocellular Carcinoma", C. H. Park, H. S. Yoo and J. H. Suh. Eur. J. Nucl. Med., 1990 16, S143.
"1-Alkyl-(or aryl-) amino-2-mehtylpropane-2-thiols. Some Bi- and Thetradentate Nitrogen-Sulfur Ligands from Schiff's Base Disulfides", James L. Cobrin, et al J. Org. Chem. 41 No. 3, 1976, pp. 489-491.
"Use of Oil Contrast Medium for Selective Drug Targeting to Tumor: Enhanced Theraputic Effect and X-Ray Image", Ken Iwai, et al Cancer Research 44, May 1984, pp. 2115-2121.
"Biodistribution and In Vivo Kinetics of Iodine-131 Lipiodol Infused via the Hepatic Artery of Patients with Hepatic Cancer", Masayuki Nakajo, et al., J. Nucl. Med., Jun. 1988, 29, No. 6 pp. 1066-1077.
"Transannular Cyclization of 1,2-Dithia-5,8-diazacyclodera-4,8-dienes during Borohydrige Reduction", Alummottil V. Joshua, et al, J. Org. Chem. 1987, 52, No. 12, pp. 2447-2451.
"Novel Synthesis of Aminoethanethiols", John J. D'Amico, et al J. Org. Chem. 1975 40, No. 9, pp. 1224-1227.
"Synthesis and Biodistribution of Neutral Lipid-Soluble Tc-99m Complexes that Cross the Blood-Brain Barrier", H. F. Kung, et al J. Nucl. Med. 1984, 25, No. 3, pp. 326-332.
"The Use of Diaminodithio for Labeling Small Molecules with Technetium-99m", F. H. Liang, et al Nucl. Med. Biol. 1987, 14 No. 1, pp. 63-67.
Jackson Timothy W.
Kojima Masaharu
Lambrecht Richard M.
Australian Nuclear Science & Technology Organisation
Chapman Lara E.
Kayden James W.
Wu Shean
LandOfFree
Rhenium complexes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rhenium complexes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rhenium complexes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1411094